Log In
Print this Print this

Ad5[E1-,E2b-]-CEA (ETBX-011)

  Manage Alerts
Collapse Summary General Information
Company Etubics Corp.
DescriptionVaccine using an adenovirus serotype 5 (Ad5) vector against carcinoembryonic antigen (CEA)
Molecular Target
Mechanism of ActionGene therapy; Vaccine
Therapeutic ModalityGene therapy: Viral vector

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today